BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1727816)

  • 21. Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled anticarcinoembryonic antigen antibodies.
    Juweid M; Sharkey RM; Swayne LC; Goldenberg DM
    Surgery; 1997 Dec; 122(6):1156-65. PubMed ID: 9426433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunoscintigraphic follow-up studies with the 99m-Tc marked monoclonal anti-CEA antibody BW 431/26].
    Fritzsche H
    Acta Med Austriaca; 1990; 17(2-3):44-6. PubMed ID: 2220267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
    Manil L; Boudet F; Motte P; Gardet P; Saccavini JC; Lumbroso JD; Schlumberger M; Caillou B; Bazin JP; Ricard M
    Cancer Res; 1989 Oct; 49(19):5480-5. PubMed ID: 2766309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
    Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
    J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of immunoscintigraphy to the diagnosis of head and neck tumours.
    De Rossi G; Maurizi M; Almadori G; Di Giuda D; Paludetti G; Cadoni G; Ottaviani F; Galli J
    Nucl Med Commun; 1997 Jan; 18(1):10-6. PubMed ID: 9061695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
    Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
    Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
    Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
    Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
    Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
    Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial.
    Bodet-Milin C; Faivre-Chauvet A; Carlier T; Rauscher A; Bourgeois M; Cerato E; Rohmer V; Couturier O; Drui D; Goldenberg DM; Sharkey RM; Barbet J; Kraeber-Bodere F
    J Nucl Med; 2016 Oct; 57(10):1505-1511. PubMed ID: 27230928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
    Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R
    Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
    Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg DM
    J Clin Oncol; 1996 Apr; 14(4):1209-17. PubMed ID: 8648376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguided surgery.
    de Labriolle-Vaylet C; Cattan P; Sarfati E; Wioland M; Billotey C; Brochériou C; Rouvier E; de Roquancourt A; Rostène W; Askienazy S; Barbet J; Milhaud G; Gruaz-Guyon A
    Clin Cancer Res; 2000 Feb; 6(2):363-71. PubMed ID: 10690512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody.
    Aarts F; Boerman OC; Sharkey RM; Hendriks T; Chang CH; McBride WJ; Bleichrodt RP; Oyen WJ; Goldenberg DM
    Cancer; 2010 Feb; 116(4 Suppl):1111-7. PubMed ID: 20127959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
    Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
    Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunoassisted follow-up and surgery vs traditional examinations and surgery after radical excision of colorectal cancer.
    Prati U; Roveda L; Cantoni A; Saponaro R; Bosi F; Sandolo R; Zonta A
    Anticancer Res; 1995; 15(3):1081-5. PubMed ID: 7645930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunoscintigraphy with emission tomography in cancers of the thyroid].
    Parmentier C; Lumbroso J; Schlumberger M; Gardet P; Mach JP; Berche C; Rougier P; Caillou B; Tubiana M
    Ann Med Interne (Paris); 1984; 135(5):345-50. PubMed ID: 6333200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of occult tumor using indium 111-labeled anticarcinoembryonic antigen antibodies.
    Halpern SE; Dillman RO; Amox D; Hagan PL; Burks R; Dillman J; Perdikakis B; Merchant B; Frincke J; Schweighardt S
    Arch Surg; 1992 Sep; 127(9):1094-100. PubMed ID: 1514913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies].
    Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G
    Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.